All Topics

Fred Lublin, MD; Aaron Miller, MD; and Stephen Krieger, MD, discuss real-world adherence and persistence to disease-modifying therapies in multiple sclerosis.

Dennis J. Selkoe, MD; Michael G. Erkkinen, MD; and Lawren VandeVrede, MD, PhD, discuss anti-amyloid treatment for MCI and dementia with confirmed amyloid pathology.